TH56074B - Inhibitor (alpha v beta 6) integrine - Google Patents
Inhibitor (alpha v beta 6) integrineInfo
- Publication number
- TH56074B TH56074B TH9901004752A TH9901004752A TH56074B TH 56074 B TH56074 B TH 56074B TH 9901004752 A TH9901004752 A TH 9901004752A TH 9901004752 A TH9901004752 A TH 9901004752A TH 56074 B TH56074 B TH 56074B
- Authority
- TH
- Thailand
- Prior art keywords
- xaa
- beta
- alpha
- leu
- arg
- Prior art date
Links
Abstract
การประดิษฐ์บรรยายถึงเพปไทด์ชนิดใหม่ ซึ่งเป็นลิแกนด์ของ(อัลฟาvเบตา6) อินทีกริน และเป็นสาร ออกฤทธิ์ทางชีวภาพ เพปไทด์ เหล่านี้ทั้งหมดมีแม่แบโครงสร้างโดยทั่วไป กล่าวคือ -Asp Leu Xaa Xaa Leu- หรือในแบบที่ควรเลือกใช้ -Arg Xaa Asp Leu Xaa Xaa Leu Arg- เมื่อ Xaa เป็นส่วนที่ เหลือของกรดอะ มิโนที่พึงประสงค์ใด ๆ เพปไทด์ตามการประดิษฐ์สามารถได้รับ การใช้เป็นตัวยับยั้ง ตัวรับ (อัลฟาvเบตา6) อินทีกริน ที่มี ประสิทธิผล และดังนั้นสำหรับการรักษาโรคต่าง ๆ และการค้นพบ ทางพยาธิ วิทยา The invention describes a new peptide These peptides are ligands of (alpha v beta 6) integrins and are bioactive compounds. All of these peptides have a typical structural parent: -Asp Leu Xaa Xaa Leu- or, in a way that should Choose -Arg Xaa Asp Leu Xaa Xaa Leu Arg- When Xaa is the rest of the amino acid. Any desirable mino, peptide based on fabrication can be obtained. Its use as a receptor inhibitor (alpha v beta 6), integral, and therefore for the treatment of various diseases and pathological findings
Claims (1)
Publications (2)
Publication Number | Publication Date |
---|---|
TH56074B true TH56074B (en) | 2003-04-01 |
TH56074A3 TH56074A3 (en) | 2003-04-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1154211A1 (en) | Prevention and reduction of blood loss and inflammatory response | |
MX9606536A (en) | N-terminally extended proteins expressed in yeast. | |
HUP9901069A2 (en) | Compounds and peptides that bind to the erythropoietin receptor | |
CA2050300A1 (en) | Tnf-inhibiting proteins and the preparation thereof | |
NO20053027L (en) | Gastrin preparations and formulations, and methods of use and preparation. | |
DE69321342D1 (en) | NEW HUMAN PROTEAS INHIBITOR OF THE KUNITZ TYPE AND CORRESPONDING VARIANTS | |
ATE162201T1 (en) | CNP GENE AND PRECURSOR PROTEIN FROM PORK | |
BR0012418A (en) | Cyclic peptide derivatives as alphavbeta6 integrin inhibitors | |
CA2196308A1 (en) | Peptide, bronchodilator and blood flow ameliorant | |
TH56074B (en) | Inhibitor (alpha v beta 6) integrine | |
RU99116976A (en) | MYELOPEPTIDES AND THEIR THERAPEUTIC USE | |
TH56074A3 (en) | Alpha v beta 6 inhibitors | |
ATE245168T1 (en) | PEPTIDES THAT EXHIBIT ANTI-CELL ADHESION ACTIVITY | |
NO20016341L (en) | Inhibitors for the integrin <alfa> v <beta> 6 | |
US6184346B1 (en) | Protease inhibitors derived from guamerin | |
FR2787454B1 (en) | TOPOISOMERASE II INHIBITOR | |
TH57872B (en) | Inhibitors of Intragrin Alpha Nubeta 6 | |
Tasaka et al. | Guinea pig eosinophil major basic protein as a potent histamine releaser.(II) Structure-activity relationships of GMBP 1 and GMBP 2 | |
RU94036002A (en) | Protease inhibitor, dna, vector, cell, method of inhibitor preparing, pharmaceutical composition | |
ES2119746T3 (en) | NEW PHYSIOLOGICALLY ACTIVE PEPTIDE AND CALCIUM METABOLISM REGULATING AGENT THAT INCLUDES SUCH PEPTIDE AS AN ACTIVE INGREDIENT. | |
ATE425988T1 (en) | PEPTIDES HAVING AFFINITY FOR A PHOSPHOLIPIDE AND THEIR USE | |
RU94036770A (en) | Protease inhibitor domain, dna, cell, method of domain preparing, pharmaceutical composition, domain use | |
Okada et al. | Amino acids and peptides. Part 31. Total synthesis of eglin c. Part 1. Synthesis of a triacontapeptide corresponding to the C-terminal sequence 41–70 of eglin c and related peptides and studies on the relationship between the structure and inhibitory activity against human leukocyte elastase, csthepsin G and α-chymotrypsin | |
CY1115911T1 (en) | MODIFIED KUNITZ AREA POLYPTIPES AND USE IN REDUCING ISCHEMIA OR STARTING A SYSTEMATIC INFECTION INFECTION | |
TH34900A (en) | Obesity-inhibiting protein |